Pebblebrook Hotel Trust has a consensus price target of $25.08 based on the ratings of 15 analysts. The high is $125 issued by Barclays on July 5, 2023. The low is $11 issued by Morgan Stanley on November 7, 2023. The 3 most-recent analyst ratings were released by Truist Securities, Compass Point, and Truist Securities on May 30, 2024, March 28, 2024, and January 18, 2024, respectively. With an average price target of $16 between Truist Securities, Compass Point, and Truist Securities, there's an implied 15.36% upside for Pebblebrook Hotel Trust from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/30/2024 | Buy Now | 8.15% | Truist Securities | Gregory Miller | $16 → $15 | Maintains | Hold | Get Alert |
03/28/2024 | Buy Now | 22.57% | Compass Point | Floris Van Dijkum | → $17 | Downgrade | Buy → Neutral | Get Alert |
01/18/2024 | Buy Now | 15.36% | Truist Securities | Gregory Miller | $15 → $16 | Maintains | Hold | Get Alert |
01/08/2024 | Buy Now | -2.67% | B of A Securities | Shaun Kelley | → $13.5 | Downgrade | Neutral → Underperform | Get Alert |
12/22/2023 | Buy Now | 15.36% | Wells Fargo | Dori Kesten | $14 → $16 | Maintains | Equal-Weight | Get Alert |
12/08/2023 | Buy Now | 0.94% | Wells Fargo | Dori Kesten | $13 → $14 | Maintains | Equal-Weight | Get Alert |
11/13/2023 | Buy Now | -6.27% | Wells Fargo | Dori Kesten | $16 → $13 | Maintains | Equal-Weight | Get Alert |
11/07/2023 | Buy Now | -20.69% | Morgan Stanley | Stephen Grambling | $12 → $11 | Maintains | Underweight | Get Alert |
10/16/2023 | Buy Now | -13.48% | Morgan Stanley | Stephen Grambling | $11 → $12 | Maintains | Underweight | Get Alert |
10/03/2023 | Buy Now | 0.94% | Wedbush | Richard Anderson | → $14 | Initiates | → Neutral | Get Alert |
09/28/2023 | Buy Now | — | Wolfe Research | Keegan Carl | — | Initiates | → Peer Perform | Get Alert |
09/22/2023 | Buy Now | 15.36% | Truist Securities | Gregory Miller | → $16 | Reiterates | Hold → Hold | Get Alert |
08/25/2023 | Buy Now | -20.69% | Morgan Stanley | Stephen Grambling | $12 → $11 | Maintains | Underweight | Get Alert |
07/14/2023 | Buy Now | 8.15% | Citigroup | Smedes Rose | $16.5 → $15 | Maintains | Neutral | Get Alert |
07/12/2023 | Buy Now | 8.15% | Wells Fargo | Dori Kesten | $14.5 → $15 | Maintains | Equal-Weight | Get Alert |
07/10/2023 | Buy Now | 15.36% | Truist Securities | Patrick Scholes | → $16 | Reiterates | Hold → Hold | Get Alert |
07/05/2023 | Buy Now | 801.23% | Barclays | Anthony Powell | $135 → $125 | Maintains | Equal-Weight | Get Alert |
06/27/2023 | Buy Now | -13.48% | Morgan Stanley | Stephen Grambling | $13 → $12 | Maintains | Underweight | Get Alert |
05/04/2023 | Buy Now | 4.54% | Wells Fargo | Dori Kesten | $14 → $14.5 | Maintains | Equal-Weight | Get Alert |
05/01/2023 | Buy Now | -6.27% | Morgan Stanley | Stephen Grambling | $12 → $13 | Maintains | Underweight | Get Alert |
04/27/2023 | Buy Now | 11.75% | Stifel | Simon Yarmak | $15.25 → $15.5 | Maintains | Hold | Get Alert |
04/26/2023 | Buy Now | 15.36% | Barclays | Anthony Powell | $18 → $16 | Maintains | Equal-Weight | Get Alert |
04/13/2023 | Buy Now | 15.36% | Truist Securities | Patrick Scholes | $18 → $16 | Maintains | Hold | Get Alert |
03/30/2023 | Buy Now | 0.94% | Wells Fargo | Dori Kesten | $17 → $14 | Maintains | Equal-Weight | Get Alert |
02/07/2023 | Buy Now | -13.48% | Morgan Stanley | Stephen Grambling | $13 → $12 | Maintains | Underweight | Get Alert |
02/02/2023 | Buy Now | 22.57% | Wells Fargo | Dori Kesten | $18 → $17 | Maintains | Equal-Weight | Get Alert |
02/01/2023 | Buy Now | 18.96% | Citigroup | Smedes Rose | $15 → $16.5 | Maintains | Neutral | Get Alert |
01/18/2023 | Buy Now | -6.27% | Morgan Stanley | Stephen Grambling | $15 → $13 | Maintains | Underweight | Get Alert |
12/21/2022 | Buy Now | 29.78% | Barclays | Anthony Powell | $22 → $18 | Maintains | Equal-Weight | Get Alert |
12/09/2022 | Buy Now | — | Raymond James | William Crow | — | Downgrade | Outperform → Market Perform | Get Alert |
12/05/2022 | Buy Now | 8.15% | Morgan Stanley | Stephen Grambling | → $15 | Initiates | → Underweight | Get Alert |
12/02/2022 | Buy Now | 29.78% | BMO Capital | Ari Klein | $20 → $18 | Downgrade | Outperform → Market Perform | Get Alert |
11/01/2022 | Buy Now | 58.62% | Raymond James | William Crow | $24 → $22 | Maintains | Outperform | Get Alert |
10/20/2022 | Buy Now | 29.78% | Truist Securities | Patrick Scholes | $24 → $18 | Maintains | Hold | Get Alert |
08/29/2022 | Buy Now | 44.2% | Wells Fargo | Dori Kesten | → $20 | Downgrade | Overweight → Equal-Weight | Get Alert |
07/07/2022 | Buy Now | 58.62% | Barclays | Anthony Powell | $26 → $22 | Maintains | Equal-Weight | Get Alert |
03/23/2022 | Buy Now | — | SMBC Nikko | Richard Anderson | — | Initiates | → Outperform | Get Alert |
01/10/2022 | Buy Now | — | B of A Securities | Shaun Kelley | — | Downgrade | Buy → Neutral | Get Alert |
01/10/2022 | Buy Now | 94.66% | Raymond James | William Crow | → $27 | Upgrade | Market Perform → Outperform | Get Alert |
01/07/2022 | Buy Now | 87.45% | BMO Capital | Ari Klein | $25 → $26 | Upgrade | Market Perform → Outperform | Get Alert |
10/06/2021 | Buy Now | 80.25% | Citigroup | — | — | Maintains | Neutral | Get Alert |
The latest price target for Pebblebrook Hotel (NYSE:PEB) was reported by Truist Securities on May 30, 2024. The analyst firm set a price target for $15.00 expecting PEB to rise to within 12 months (a possible 8.15% upside). 13 analyst firms have reported ratings in the last year.
The latest analyst rating for Pebblebrook Hotel (NYSE:PEB) was provided by Truist Securities, and Pebblebrook Hotel maintained their hold rating.
The last upgrade for Pebblebrook Hotel Trust happened on January 10, 2022 when Raymond James raised their price target to $27. Raymond James previously had a market perform for Pebblebrook Hotel Trust.
The last downgrade for Pebblebrook Hotel Trust happened on March 28, 2024 when Compass Point changed their price target from N/A to $17 for Pebblebrook Hotel Trust.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Pebblebrook Hotel, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Pebblebrook Hotel was filed on May 30, 2024 so you should expect the next rating to be made available sometime around May 30, 2025.
While ratings are subjective and will change, the latest Pebblebrook Hotel (PEB) rating was a maintained with a price target of $16.00 to $15.00. The current price Pebblebrook Hotel (PEB) is trading at is $13.87, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.